Sodium Sulfite vs Blue Dye 2: which is worse?

What is Sodium Sulfite?

Sodium sulfite is an inorganic sulfite salt used as a food preservative and antioxidant. It releases sulfur dioxide when it contacts water or acid, which acts as the active antimicrobial and antioxidant agent. Part of the broader sulfite family of food additives (including sulfur dioxide E220, sodium bisulfite E222, and others).

What is Blue Dye 2?

Blue Dye 2 (Indigotine/Indigo Carmine) is a synthetic disulfonated derivative of indigo. Unlike natural indigo from the indigo plant, the FD&C version is synthetically manufactured from petroleum. It produces a dark royal blue to indigo color and is used in food, pharmaceuticals, and medical diagnostics.

Documented risks

Sodium Sulfite: Sulfites are among the more significant food allergy/intolerance triggers. An estimated 1 in 100 people, and up to 5% of asthmatics, are sulfite-sensitive. Reactions can include urticaria, angioedema, bronchospasm, and in severe cases anaphylaxis. Sulfite-induced asthma can be severe; several deaths attributable to sulfite-triggered anaphylaxis have been documented. The FDA banned sulfites from fresh produce and restaurant salad bars in 1986 after several deaths and severe reactions were linked to sulfite-treated salads. FDA mandates that sulfite content above 10 ppm be declared on US food labels. All forms of sulfites (E220-E228) share these sensitization concerns.

Blue Dye 2: Animal studies conducted in the 1980s found that high-dose Blue Dye 2 caused brain tumors in male rats. An NTP bioassay (1987) found statistically significant increases in brain gliomas (astrocytomas) in male rats given high doses. The FDA reviewed these findings and determined that the doses far exceeded typical human dietary exposure. Nonetheless, the tumor finding remains in the scientific record as a concerning data point. EFSA's 2010 safety evaluation of Indigo Carmine (E132) reached an unusual conclusion: it could not establish an ADI due to data limitations, including the brain tumor findings. This means EFSA adopted an implicit conservative position — it neither declared Blue 2 safe nor formally banned it, but the absence of an established ADI signals scientific uncertainty. In medical diagnostic use, high intravenous doses of Indigo Carmine can cause hypertension, bradycardia, and in rare cases anaphylaxis. These are dose-specific clinical pharmacological effects, not relevant to dietary consumption at food use levels. Blue 2 was not included in the 2007 Lancet hyperactivity study. Limited direct research links Blue 2 to behavioral effects. The FDA's April 2025 announcement includes Blue 2 in the class of petroleum-based synthetic dyes to be phased out of the US food supply, reflecting updated policy on the category rather than specific new Blue 2 toxicity data.